These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1. Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ; Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855 [TBL] [Abstract][Full Text] [Related]
3. The latest reports and treatment methods on polycystic ovary syndrome. Stańczak NA; Grywalska E; Dudzińska E Ann Med; 2024 Dec; 56(1):2357737. PubMed ID: 38965663 [TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism. Hassa H; Tanir HM; Yildiz Z Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383 [TBL] [Abstract][Full Text] [Related]
9. Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment. Spritzer PM; Motta AB Int J Clin Pract; 2015 Nov; 69(11):1236-46. PubMed ID: 26289303 [TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome and metabolic disorders: A review of the literature. Ali AT; Al-Ani O; Al-Ani F; Guidozzi F Afr J Reprod Health; 2022 Aug; 26(8):89-99. PubMed ID: 37585035 [TBL] [Abstract][Full Text] [Related]
12. Hyperandrogenism. Yadav V; Sharma Y Indian J Pediatr; 2023 Oct; 90(10):1018-1024. PubMed ID: 37402107 [TBL] [Abstract][Full Text] [Related]
13. Managing polycystic ovary syndrome in primary care. Lua ACY; How CH; King TFJ Singapore Med J; 2018 Nov; 59(11):567-571. PubMed ID: 30498839 [TBL] [Abstract][Full Text] [Related]
14. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria? Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of polycystic ovary syndrome and its clinical and hormonal profile in young females with type 1 diabetes mellitus: experience from a teaching institution of India. Dominic N; Sharma L; Mohindra N; Dabadghao P Endocrine; 2023 Nov; 82(2):303-310. PubMed ID: 37615813 [TBL] [Abstract][Full Text] [Related]
16. PCOS in adolescence and type 2 diabetes. Carreau AM; Baillargeon JP Curr Diab Rep; 2015 Jan; 15(1):564. PubMed ID: 25398203 [TBL] [Abstract][Full Text] [Related]
17. Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study. West S; Lashen H; Bloigu A; Franks S; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Morin-Papunen L Hum Reprod; 2014 Oct; 29(10):2339-51. PubMed ID: 25085801 [TBL] [Abstract][Full Text] [Related]
18. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka. Kumarapeli V; Seneviratne Rde A; Wijeyaratne CN; Yapa RM; Dodampahala SH Am J Epidemiol; 2008 Aug; 168(3):321-8. PubMed ID: 18550559 [TBL] [Abstract][Full Text] [Related]
19. Polycystic ovary syndrome and metabolic syndrome. Ali AT Ceska Gynekol; 2015 Aug; 80(4):279-89. PubMed ID: 26265416 [TBL] [Abstract][Full Text] [Related]
20. Diagnosis and management of polycystic ovary syndrome: a practical guide. Stankiewicz M; Norman R Drugs; 2006; 66(7):903-12. PubMed ID: 16740005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]